Preview

User

Not a user? Register with this site Forgot your password?

Cardiovascular Therapy and Prevention

Advanced search
Fullscreen

For citations:

Podzolkov V.I., Tarzimanova A.I., Bragina A.E., Shvedov I.I., Bykova E.E., Ivannikov А.A., Khanakyan S.S., Almyasheva A.M. Effect of spironolactone therapy on the activity of the matrix metalloproteinase system in patients with heart failure after COVID-19. Cardiovascular Therapy and Prevention. 2022;21(10):3431. (In Russ.) https://doi.org/10.15829/1728-8800-2022-3431

Views PDF (Rus): 308


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)

101000, Moscow, Petroverigsky per., 10, str. 3
National medical research center for therapy and preventive medicine

Тел: +7 (499) 553 67 78

Editorial office Cardiovascular Therapy and Prevention

supported by NEICON (Elpub lab)